Safety Study of GRNOPC1 in Spinal Cord Injury
Trial ID or NCT#
The purpose of the study is to evaluate the safety of GRNOPC1 administered at a single time-point between 7 and 14 days post injury, inclusive, to patients with neurologically complete spinal cord injuries (SCI).
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToMaria Coburn
Go Back To The Trial